查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1471075

感染控制市場：按感染、產品和最終用戶分類 - 2024-2030 年全球預測

Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年感染控制市場規模為436.2億美元，預計2024年將達457.9億美元，2030年將達到623.6億美元，複合年成長率為5.23%。

感染控制是指防止感染疾病傳播的嚴格方法和做法。這個多方面的學術領域涉及確定感染源、了解感染疾病傳播的機制以及實施策略措施以減輕傳染源的傳播。科學、理論和實踐相結合，保護醫護人員、病人和公眾免受傳染病的風險。由於醫院感染發生率上升、感染疾病爆發期間感染控制意識和需求不斷提高、滅菌技術的進步、醫療基礎設施的擴大以及有關感染預防措施的嚴格全球法規，感染控制市場有望強勁成長。市場開拓機會包括開發環保消毒方法、引入物聯網和人工智慧進行衛生管理、進入醫療標準不斷提高的新興市場以及開發處理傳染性廢棄物的創新方法等解決方案。然而，諸如先進滅菌設備的高成本、低收入地區的認知和實踐有限、醫護人員因缺乏培訓而抵制以及對感染性廢棄物處理的環境問題等挑戰仍然成為顯著的障礙。為了實現持續成長，該產業專注於具有成本效益的滅菌技術、環保的一次性產品、自動化即時感染控制監測，並努力使感染控制解決方案更容易獲得且負擔得起，需要協作努力等技術創新。

主要市場統計
基準年[2023] 436.2億美元
預測年份 [2024] 457.9億美元
預測年份 [2030] 623.6億美元
複合年成長率（%） 5.23%

為了確保製造的醫療設備的安全，使用滅菌來去除包括孢子在內的所有型態的微生物的方法正在迅速增加。

此類別包括旨在消除或減少表面、設備和皮膚上的有害病原體的產品。乾洗手劑的配製是為了殺死或抑制人們手上的細菌生長。在醫療保健環境中，防止交叉污染和感染非常重要。器械消毒劑用於醫療器械滅菌消毒，降低感染傳播風險。皮膚消毒劑是用於在醫療程序之前或接觸污染物之後去除皮膚上的微生物的消毒劑。表面消毒劑是旨在對各種環境下的表面進行消毒的產品，有效降低傳播感染的風險。消毒過程中使用的設備和機械提高了效率和效果。 Flasher 消毒器是一種自動化系統，用於對醫療設備和管道設備清洗和消毒，以防止微生物污染。超音波清洗透過超音波照射清洗液來去除污染物，對於精密儀器特別有效。紫外線消毒器可發射 UV-C 光來消滅細菌、病毒和真菌病原體，適用於對錶面、水和空氣進行消毒。清洗消毒機在高溫下有效運行，對醫療器材進行徹底清洗消毒。消毒劑的物理成分根據不同的應用和偏好而量身定做。消毒噴霧劑是液體製劑，可輕鬆塗布在表面或空氣中，提供快速方便的消毒效果。消毒濕紙巾是浸有消毒劑溶液的濕紙巾，是快速清潔和消毒表面的理想選擇。液體消毒劑可以直接塗布或稀釋後用於各種消毒任務。消毒方法根據其殺菌活性程度進行分類，對於為各種應用選擇合適的產品非常重要。高水平消毒可消滅除大量細菌孢子外的所有微生物。用於與無菌身體部位接觸的物品。中等程度惰性病毒、細菌、真菌和分枝桿菌，但不一定會惰性大量細菌孢子。

低濃度可消除大多數細菌、部分病毒和真菌，但不會殺死分枝桿菌或孢子形成細菌，適用於非關鍵表面。內視鏡再處理對於預防與內視鏡使用相關的感染至關重要，需要特定的程序和產品來確保徹底消毒。消耗品包括專門用於清洗和消毒內視鏡的清潔劑、擦拭巾和刷子。防護屏障是提供物理屏障並保護醫護人員和病患免受感染源影響的設備或材料。蓋子和封閉物旨在密封或覆蓋設備或區域以防止污染。護目鏡可以保護您的眼睛免受飛沫、噴霧劑和可能含有傳染性物質的飛沫的侵害。醫用不織布是醫療環境中用來防止交叉污染的一次性織物，例如罩衣、手術單和口罩。滅菌是醫療機構採用的過程，透過消除包括孢子在內的所有型態的微生物生命來確保醫療設備的安全。電子束滅菌利用電子束快速有效地對適合多種材料的醫療產品進行滅菌。器械滅菌使用蒸氣、乾熱和化學物質等方法對醫療設備進行滅菌，以便可以安全地重複使用。 ETO滅菌使用環氧乙烷氣體對醫療設備進行滅菌，對於對熱和濕氣敏感的材料有效。過濾滅菌透過過濾物理性去除微生物，適用於熱敏性液體。伽瑪滅菌利用伽瑪射線穿透產品徹底滅菌，常用於一次性醫療設備。放射線殺菌包括伽馬射線和電子束滅菌，並深入滲透到各種產品中。蒸氣滅菌是一種廣泛使用且有效的方法，利用加壓蒸氣來實現微生物惰性，對於耐熱設備來說是理想的選擇。

最終使用者：擴大醫院和診所感染控制的使用

在食品和飲料行業，感染控制包括透過嚴格的衛生管理和消毒來預防食物中毒。此細分市場需要針對多種病原體的有效解決方案，同時又能在食品加工環境中安全使用。成長機會在於創新的消毒技術和符合食品安全監管標準的環保消毒劑。醫療保健和診所仍然處於感染控制的最前沿，因為預防醫療保健相關感染 (HAI) 至關重要。醫院和診所需要全面的解決方案，包括滅菌設備、消毒劑和服務，以確保患者照護的無菌環境。技術的進步和對病人安全標準的日益重視正在推動對高效產品和服務的需求。生命科學產業，包括研究機構和生物技術公司，需要採取嚴格的措施來確保研究和生產過程的完整性。生命科學產業需要能夠無縫整合到業務中的創新滅菌和淨化技術。我們專注於提供有效的解決方案，而不影響敏感材料或實驗結果。對於醫療設備公司來說，感染控制對於醫療產品的設計、製造和使用至關重要。這就需要採用滅菌製程和塗層來防止設備受到微生物污染，尤其是那些涉及侵入性手術的設備。與感染控制專家合作，他們可以根據您的特定設備要求提供自訂解決方案，這是一個策略機會。製藥公司需要感染控制以確保其產品和無塵室環境的無菌性。製藥公司對在製造過程中保持無菌和防止交叉污染的技術和服務感興趣。這些公司通常在全球範圍內營運，增加了對符合國際標準且擴充性的解決方案的需求。

區域洞察

在 CDC 和 FDA 等嚴格監管指南的推動下，美洲先進感染控制技術的採用率很高。該地區有多家公司進入感染控制市場，為全球產能做出了重大貢獻。此外，我們也高度重視研究和創新，使感染控制方法持續進步。相反，亞太地區是該領域成長最快的地區。這是由於健康和衛生習慣意識的提高、醫療保健成本的上升以及醫療保健基礎設施的擴張，特別是在中國和印度等國家。該地區的生產由國內和國際公司混合而成，並且正在努力擴大製造能力以滿足不斷成長的需求。歐洲、中東和非洲地區具有多樣性，歐洲國家在醫療保健法規和高品質標準的推動下擁有完善的感染控制實踐。中東和非洲地區面臨醫療設施和技術不平等的挑戰，但這些挑戰正在緩慢改善。該地區是許多國內和國際公司的所在地，這些公司希望向服務不足的地區擴張，這展示了感染控制實踐的成長潛力。

FPNV定位矩陣

FPNV定位矩陣對於評估感染控制市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對感染控制市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.感染控制市場的市場規模和預測是多少？

2.在感染控制市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3.感染控制市場的技術趨勢和法規結構是什麼？

4.感染控制市場主要廠商的市場佔有率為何？

5. 進入感染控制市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫院感染發生率上升和感染控制產品的快速使用
      • 外科手術的增加和採取適當安全措施的必要性
      • 感染控制產品在醫療設備和製藥業的快速採用
    • 抑制因素
      • 與化學消毒劑相關的副作用
    • 機會
      • 醫院和診所增加滅菌服務外包
      • 製造商增加感染控制產品生產的投資
    • 任務
      • 替代感染控制產品和技術的可用性
  • 市場區隔分析
    • 產品：滅菌的使用正在迅速增加，以通過去除包括孢子在內的所有型態的微生物來確保醫療設備的安全。
    • 最終使用者：不斷發展醫院和診所部門感染控制的使用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 感染控制市場傳播

  • 空氣
  • 血源性的
  • 合約

第7章感染控制市場：依產品

  • 清潔消毒
  • 內視鏡再處理
  • 防護屏障
  • 消毒

第8章感染控制市場：依最終用戶分類

  • 食品和飲料公司
  • 醫院/診所
  • 生命科學產業
  • 醫療設備公司
  • 製藥公司

第9章美洲感染控制市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太感染控制市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的感染控制市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 科德寶醫療在哥斯大黎加建立第二個生產工廠
    • WPT 非織造佈公司在肯塔基州製造工廠投資 1,950 萬美元，以促進當地經濟
    • Berry 推出了輕型管封閉解決方案，符合感染控制通訊協定規定的嚴格安全和衛生標準。
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-43676CF42B0E

[195 Pages Report] The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.79 billion in 2024, at a CAGR 5.23% to reach USD 62.36 billion by 2030.

Infection control refers to the disciplined approach and practices designed to prevent the spreading of infectious diseases. This multifaceted discipline encompasses identifying sources of infections, understanding the mechanisms through which infections spread, and implementing strategic measures to mitigate the transmission of infectious agents. It involves a combination of science, theory, and practices to protect healthcare providers, patients, and the public from the dangers of contagious diseases. The infection control market is experiencing robust growth, driven by the rise of hospital-acquired infection incidence, heightened awareness and demand for infection control amidst infectious disease outbreaks, advancements in sterilization technologies, expanding healthcare infrastructure, and stringent global regulations on infection prevention practices. Opportunities for market expansion include the development of eco-friendly disinfection methods, implementation of IoT and AI for hygiene management, entry into emerging markets with rising healthcare standards, and innovative solutions for the disposal of infectious waste. Nonetheless, challenges such as the high costs of advanced sterilization equipment, limited awareness and practice adoption in lower-income regions, healthcare worker resistance due to training deficiencies, and environmental concerns over infectious waste disposal are notable barriers. To achieve sustained growth, the sector is poised for innovation in cost-effective sterilization technologies, eco-friendly disposable products, automated and real-time infection control monitoring, and collaborative efforts to make infection control solutions more accessible and affordable worldwide.

KEY MARKET STATISTICS
Base Year [2023] USD 43.62 billion
Estimated Year [2024] USD 45.79 billion
Forecast Year [2030] USD 62.36 billion
CAGR (%) 5.23%

Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices

Cleaning & disinfection are essential in preventing the spread of infection, this category includes products designed to eliminate or reduce harmful pathogens on surfaces, instruments, and skin. Hand Disinfectants are formulated to kill or inhibit the growth of germs on human hands. These are crucial in healthcare settings to prevent cross-contamination and infections. Instrument disinfectants are used for sterilizing and disinfecting medical instruments, reducing the risk of infection transmission. Skin disinfectants are antiseptic agents used to cleanse the skin of microbes before medical procedures or after exposure to contaminants. Surface disinfectants are products designed to sanitize surfaces in various environments, effectively reducing the risk of spreading infections. Devices and machines used in the disinfection process enhance efficiency and effectiveness. Flusher disinfectors are automated systems for the cleaning and Disinfection of medical devices and plumbing fixtures to prevent microbial contamination. Ultrasonic cleaners use ultrasonic waves in a cleaning solution to remove contaminants from items, which is particularly effective for delicate instruments. UV-Ray disinfectors that deploy UV-C light to destroy bacterial, viral, and fungal pathogens suitable for surface, water, and air disinfection. Washer disinfectors thoroughly clean and disinfect medical utensils, operating effectively at high temperatures. The physical composition of disinfection agents is tailored for various uses and preferences. Disinfectant sprays are liquid formulations designed for easy application on surfaces or air, offering quick and convenient Disinfection. Disinfectant wipes are pre-moistened towelettes impregnated with disinfectant solutions, ideal for quick cleanup and Disinfection of surfaces. Liquid disinfectants can be applied directly or diluted used for a broad range of disinfection tasks. Disinfection practices are categorized by the extent of microbicidal activity, which is important in selecting the appropriate products for various applications. High-Level Disinfection destroys all microorganisms, except large numbers of bacterial spores. Used for items that come in contact with sterile body areas. Intermediate-level inactivates viruses, bacteria, fungi, and mycobacteria, but not necessarily high numbers of bacterial spores.

Low-level eliminates most bacteria, some viruses, and fungi but does not kill mycobacteria or spores and is suitable for non-critical surfaces. Endoscope reprocessing is critical for preventing infections associated with endoscope use, involving specific steps and products to ensure thorough Disinfection. Consumables include detergents, wipes, and brushes specifically designed for cleaning and disinfecting endoscopes. Protective Barriers are quipment and materials that provide a physical barrier, protecting healthcare workers and patients from infectious agents. Covers & closures are designed to seal or cover equipment and areas to prevent contamination. Goggles protect eyes from splashes, sprays, and droplets that may contain infectious agents. Medical nonwovens are disposable fabrics used in medical settings to prevent cross-contamination, including gowns, drapes, and masks. Sterilization is the process that eliminates all forms of microbial life, including spores, employed in healthcare facilities to ensure the safety of medical devices. E-Beam sterilization utilizes electron beams to sterilize medical products quickly and effectively, suitable for various materials. Equipment sterilization involves methods such as steam, dry heat, and chemicals to sterilize medical equipment, ensuring its safe reuse. ETO sterilization uses ethylene oxide gas to sterilize medical devices, effective for materials sensitive to heat and moisture. Filtration sterilization employs physical removal of microorganisms through a filtration membrane, suitable for heat-sensitive liquids. Gamma sterilization relies on gamma rays to penetrate and sterilize products thoroughly, commonly used for single-use medical devices. Radiation sterilization encompasses gamma and e-beam sterilization, offering deep penetration for various products. Steam sterilization is a widely used, effective method utilizing pressurized steam to achieve microbial inactivation, ideal for heat-resistant devices.

End-User: Evolving usage of infection control in hospitals & clinics sector

In the food and beverage sector, infection control prevents foodborne illnesses through stringent hygiene and sanitization practices. This market segment demands effective solutions against a broad spectrum of pathogens yet safe for use in food processing environments. Growth opportunities lie in innovative disinfection technologies and eco-friendly sanitizers that meet regulatory standards for food safety. Hospitals and clinics remain at the forefront of infection control due to the critical need to prevent healthcare-associated infections (HAIs). Hospitals and clinics require comprehensive solutions, including sterilization equipment, disinfectants, and services that ensure a sterile environment for patient care. Advances in technology and increased emphasis on patient safety standards drive demand for high-efficiency products and services. The life sciences industry, encompassing research laboratories and biotech companies, necessitates stringent infection control measures to ensure the integrity of research and production processes. The life sciences industry seeks innovative sterilization and decontamination technologies that seamlessly integrate into their operations. The focus is on effective solutions without compromising sensitive materials or experimental outcomes. For medical device companies, infection control is pivotal in medical product design, manufacture, and usage. The demand here is for sterilization processes and coatings that prevent microbial contamination of devices, particularly those involved in invasive procedures. Partnering with infection control specialists who can offer custom solutions tailored to specific device requirements represents a strategic opportunity. Pharmaceutical companies need infection control to ensure the sterility of products and the cleanroom environments in which they are produced. Pharmaceutical companies are interested in technologies and services that maintain aseptic conditions and prevent cross-contamination during manufacturing. As these companies often operate globally, there is a growing demand for compliance with international standards and scalable solutions.

Regional Insights

The Americas have demonstrated high adoption rates of advanced infection control technologies, driven by stringent regulatory guidelines from agencies such as the CDC and FDA. This region is home to several companies in the infection control market, contributing significantly to global production capabilities. Furthermore, there is a strong focus on research and innovation, enabling continuous advancements in infection control methods. Conversely, the APAC region is witnessing the fastest growth in this sector, attributed to rising awareness of health and hygiene practices, increasing healthcare expenditures, and expanding healthcare infrastructure, especially in countries such as China and India. The production landscape here is marked by a mix of local and international companies, with efforts to expand manufacturing capabilities to meet the growing demand. The EMEA region presents a diverse picture, with well-established infection control practices in European countries driven by healthcare regulations and high-quality standards. The Middle East and Africa, while gradually improving, face challenges related to uneven access to healthcare facilities and technologies. This region hosts a blend of domestic and international companies focusing on expanding their reach to underserved areas, underscoring the potential for growth in infection control practices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Transmission
    • Airborne
    • Bloodborne
    • Contract
  • Products
    • Cleaning & Disinfection
      • Disinfectants
        • Hand Disinfectants
        • Instrument Disinfectants
        • Skin Disinfectants
        • Surface Disinfectants
      • Equipment
        • Flusher Disinfectors
        • Ultrasonic Cleaners
        • UV-Ray Disinfectors
        • Washer Disinfectors
      • Formulation
        • Disinfectant Sprays
        • Disinfectant Wipes
        • Liquid Disinfectants
      • Level of Disinfection
        • High-Level
        • Intermediate-Level
        • Low-Level
    • Endoscope Reprocessing
      • Consumables
      • Equipment
    • Protective Barriers
      • Covers & Closures
      • Goggles
      • Medical Nonwovens
    • Sterilization
      • E-Beam Sterilization
      • Equipment Sterilization
      • ETO Sterilization
      • Filtration Sterilization
      • Gamma Sterilization
      • Radiation Sterilization
      • Steam Sterilization
  • End-User
    • Food & Beverage Companies
    • Hospitals & Clinics
    • Life Sciences Industry
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Infection Control Market?

4. What is the market share of the leading vendors in the Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Infection Control Market?

[195 Pages Report] The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.79 billion in 2024, at a CAGR 5.23% to reach USD 62.36 billion by 2030.

Infection control refers to the disciplined approach and practices designed to prevent the spreading of infectious diseases. This multifaceted discipline encompasses identifying sources of infections, understanding the mechanisms through which infections spread, and implementing strategic measures to mitigate the transmission of infectious agents. It involves a combination of science, theory, and practices to protect healthcare providers, patients, and the public from the dangers of contagious diseases. The infection control market is experiencing robust growth, driven by the rise of hospital-acquired infection incidence, heightened awareness and demand for infection control amidst infectious disease outbreaks, advancements in sterilization technologies, expanding healthcare infrastructure, and stringent global regulations on infection prevention practices. Opportunities for market expansion include the development of eco-friendly disinfection methods, implementation of IoT and AI for hygiene management, entry into emerging markets with rising healthcare standards, and innovative solutions for the disposal of infectious waste. Nonetheless, challenges such as the high costs of advanced sterilization equipment, limited awareness and practice adoption in lower-income regions, healthcare worker resistance due to training deficiencies, and environmental concerns over infectious waste disposal are notable barriers. To achieve sustained growth, the sector is poised for innovation in cost-effective sterilization technologies, eco-friendly disposable products, automated and real-time infection control monitoring, and collaborative efforts to make infection control solutions more accessible and affordable worldwide.

KEY MARKET STATISTICS
Base Year [2023] USD 43.62 billion
Estimated Year [2024] USD 45.79 billion
Forecast Year [2030] USD 62.36 billion
CAGR (%) 5.23%

Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices

Cleaning & disinfection are essential in preventing the spread of infection, this category includes products designed to eliminate or reduce harmful pathogens on surfaces, instruments, and skin. Hand Disinfectants are formulated to kill or inhibit the growth of germs on human hands. These are crucial in healthcare settings to prevent cross-contamination and infections. Instrument disinfectants are used for sterilizing and disinfecting medical instruments, reducing the risk of infection transmission. Skin disinfectants are antiseptic agents used to cleanse the skin of microbes before medical procedures or after exposure to contaminants. Surface disinfectants are products designed to sanitize surfaces in various environments, effectively reducing the risk of spreading infections. Devices and machines used in the disinfection process enhance efficiency and effectiveness. Flusher disinfectors are automated systems for the cleaning and Disinfection of medical devices and plumbing fixtures to prevent microbial contamination. Ultrasonic cleaners use ultrasonic waves in a cleaning solution to remove contaminants from items, which is particularly effective for delicate instruments. UV-Ray disinfectors that deploy UV-C light to destroy bacterial, viral, and fungal pathogens suitable for surface, water, and air disinfection. Washer disinfectors thoroughly clean and disinfect medical utensils, operating effectively at high temperatures. The physical composition of disinfection agents is tailored for various uses and preferences. Disinfectant sprays are liquid formulations designed for easy application on surfaces or air, offering quick and convenient Disinfection. Disinfectant wipes are pre-moistened towelettes impregnated with disinfectant solutions, ideal for quick cleanup and Disinfection of surfaces. Liquid disinfectants can be applied directly or diluted used for a broad range of disinfection tasks. Disinfection practices are categorized by the extent of microbicidal activity, which is important in selecting the appropriate products for various applications. High-Level Disinfection destroys all microorganisms, except large numbers of bacterial spores. Used for items that come in contact with sterile body areas. Intermediate-level inactivates viruses, bacteria, fungi, and mycobacteria, but not necessarily high numbers of bacterial spores. Low-level eliminates most bacteria, some viruses, and fungi but does not kill mycobacteria or spores and is suitable for non-critical surfaces. Endoscope reprocessing is critical for preventing infections associated with endoscope use, involving specific steps and products to ensure thorough Disinfection. Consumables include detergents, wipes, and brushes specifically designed for cleaning and disinfecting endoscopes. Protective Barriers are quipment and materials that provide a physical barrier, protecting healthcare workers and patients from infectious agents. Covers & closures are designed to seal or cover equipment and areas to prevent contamination. Goggles protect eyes from splashes, sprays, and droplets that may contain infectious agents. Medical nonwovens are disposable fabrics used in medical settings to prevent cross-contamination, including gowns, drapes, and masks. Sterilization is the process that eliminates all forms of microbial life, including spores, employed in healthcare facilities to ensure the safety of medical devices. E-Beam sterilization utilizes electron beams to sterilize medical products quickly and effectively, suitable for various materials. Equipment sterilization involves methods such as steam, dry heat, and chemicals to sterilize medical equipment, ensuring its safe reuse. ETO sterilization uses ethylene oxide gas to sterilize medical devices, effective for materials sensitive to heat and moisture. Filtration sterilization employs physical removal of microorganisms through a filtration membrane, suitable for heat-sensitive liquids. Gamma sterilization relies on gamma rays to penetrate and sterilize products thoroughly, commonly used for single-use medical devices. Radiation sterilization encompasses gamma and e-beam sterilization, offering deep penetration for various products. Steam sterilization is a widely used, effective method utilizing pressurized steam to achieve microbial inactivation, ideal for heat-resistant devices.

End-User: Evolving usage of infection control in hospitals & clinics sector

In the food and beverage sector, infection control prevents foodborne illnesses through stringent hygiene and sanitization practices. This market segment demands effective solutions against a broad spectrum of pathogens yet safe for use in food processing environments. Growth opportunities lie in innovative disinfection technologies and eco-friendly sanitizers that meet regulatory standards for food safety. Hospitals and clinics remain at the forefront of infection control due to the critical need to prevent healthcare-associated infections (HAIs). Hospitals and clinics require comprehensive solutions, including sterilization equipment, disinfectants, and services that ensure a sterile environment for patient care. Advances in technology and increased emphasis on patient safety standards drive demand for high-efficiency products and services. The life sciences industry, encompassing research laboratories and biotech companies, necessitates stringent infection control measures to ensure the integrity of research and production processes. The life sciences industry seeks innovative sterilization and decontamination technologies that seamlessly integrate into their operations. The focus is on effective solutions without compromising sensitive materials or experimental outcomes. For medical device companies, infection control is pivotal in medical product design, manufacture, and usage. The demand here is for sterilization processes and coatings that prevent microbial contamination of devices, particularly those involved in invasive procedures. Partnering with infection control specialists who can offer custom solutions tailored to specific device requirements represents a strategic opportunity. Pharmaceutical companies need infection control to ensure the sterility of products and the cleanroom environments in which they are produced. Pharmaceutical companies are interested in technologies and services that maintain aseptic conditions and prevent cross-contamination during manufacturing. As these companies often operate globally, there is a growing demand for compliance with international standards and scalable solutions.

Regional Insights

The Americas have demonstrated high adoption rates of advanced infection control technologies, driven by stringent regulatory guidelines from agencies such as the CDC and FDA. This region is home to several companies in the infection control market, contributing significantly to global production capabilities. Furthermore, there is a strong focus on research and innovation, enabling continuous advancements in infection control methods. Conversely, the APAC region is witnessing the fastest growth in this sector, attributed to rising awareness of health and hygiene practices, increasing healthcare expenditures, and expanding healthcare infrastructure, especially in countries such as China and India. The production landscape here is marked by a mix of local and international companies, with efforts to expand manufacturing capabilities to meet the growing demand. The EMEA region presents a diverse picture, with well-established infection control practices in European countries driven by healthcare regulations and high-quality standards. The Middle East and Africa, while gradually improving, face challenges related to uneven access to healthcare facilities and technologies. This region hosts a blend of domestic and international companies focusing on expanding their reach to underserved areas, underscoring the potential for growth in infection control practices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Transmission
    • Airborne
    • Bloodborne
    • Contract
  • Products
    • Cleaning & Disinfection
      • Disinfectants
        • Hand Disinfectants
        • Instrument Disinfectants
        • Skin Disinfectants
        • Surface Disinfectants
      • Equipment
        • Flusher Disinfectors
        • Ultrasonic Cleaners
        • UV-Ray Disinfectors
        • Washer Disinfectors
      • Formulation
        • Disinfectant Sprays
        • Disinfectant Wipes
        • Liquid Disinfectants
      • Level of Disinfection
        • High-Level
        • Intermediate-Level
        • Low-Level
    • Endoscope Reprocessing
      • Consumables
      • Equipment
    • Protective Barriers
      • Covers & Closures
      • Goggles
      • Medical Nonwovens
    • Sterilization
      • E-Beam Sterilization
      • Equipment Sterilization
      • ETO Sterilization
      • Filtration Sterilization
      • Gamma Sterilization
      • Radiation Sterilization
      • Steam Sterilization
  • End-User
    • Food & Beverage Companies
    • Hospitals & Clinics
    • Life Sciences Industry
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Infection Control Market?

4. What is the market share of the leading vendors in the Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Infection Control Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
      • 5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
      • 5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with chemical based disinfectants
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
      • 5.1.3.2. Growing investments by manufacturers in the production of infection control products
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of substitute products and techniques for infection control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
    • 5.2.2. End-User: Evolving usage of infection control in hospitals & clinics sector
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Infection Control Market, by Transmission

  • 6.1. Introduction
  • 6.2. Airborne
  • 6.3. Bloodborne
  • 6.4. Contract

7. Infection Control Market, by Products

  • 7.1. Introduction
  • 7.2. Cleaning & Disinfection
  • 7.3. Endoscope Reprocessing
  • 7.4. Protective Barriers
  • 7.5. Sterilization

8. Infection Control Market, by End-User

  • 8.1. Introduction
  • 8.2. Food & Beverage Companies
  • 8.3. Hospitals & Clinics
  • 8.4. Life Sciences Industry
  • 8.5. Medical Device Companies
  • 8.6. Pharmaceutical Companies

9. Americas Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Freudenberg Medical Establishes Second Production Facility In Costa Rica
    • 12.3.2. WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy
    • 12.3.3. Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INFECTION CONTROL MARKET DYNAMICS
  • FIGURE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INFECTION CONTROL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 106. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 107. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 108. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 109. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 110. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 111. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 112. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 113. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 114. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 115. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 116. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 117. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 118. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 119. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 120. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 121. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 122. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 123. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 124. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 125. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 126. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 127. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 128. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 129. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 130. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 131. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 132. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 133. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 137. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 138. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 139. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 140. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 141. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 142. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 143. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 144. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 145. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 146. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 147. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 148. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 149. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 150. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 151. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 152. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 153. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 154. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 155. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 156. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 157. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 160. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 161. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 162. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 163. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 164. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 165. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 166. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 167. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 168. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 169. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 170. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 171. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 172. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 173. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 174. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 175. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 176. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 177. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 178. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 179. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 182. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 183. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 184. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 185. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 186. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 187. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 188. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 189. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 190. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 191. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 192. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 193. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 194. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 195. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 196. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 197. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 198. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 199. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 200. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 201. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 204. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 205. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 206. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 207. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 208. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 209. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 210. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 211. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 212. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 213. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 214. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 215. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 216. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 217. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 218. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 219. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 220. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 221. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 222. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 223. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 226. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 227. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 228. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 229. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 230. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 231. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 232. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 233. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 234. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 235. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 236. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 237. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 238. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 239. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 240. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 241. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 242. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 243. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 244. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 245. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 248. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 273. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 274. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 275. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 276. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 277. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 278. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 279. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 280. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 281. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 282. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 283. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 284. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 285. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 286. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 287. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 288. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 289. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 290. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 291. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 292. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 293. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 296. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 297. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 298. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 299. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 300. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 301. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 302. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 303. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 304. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 305. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 306. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 307. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 308. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 309. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 310. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 311. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 312. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 313. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 314. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 315. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 318. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 319. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 320. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 321. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 322. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 323. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 324. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 325. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 326. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 327. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 328. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 329. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 330. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 331. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 332. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 333. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 334. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 335. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 336. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 337. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 340. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MIL